We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Persistent Urinary Albumin May Indicate Risk for Cognitive Decline in Type II Diabetics

By LabMedica International staff writers
Posted on 10 Sep 2013
Print article
The chronic presence of albumin in the urine (albuminuria) of individuals with type II diabetes has been linked to a gradual decline in their ability to process information (i.e., cognitive decline).

Investigators at Kaiser Permanente of Georgia/Emory School of Medicine (Duluth, GA, USA) determined the level of albumin in urine samples obtained from participants in the Action to Control Cardiovascular Risk in Diabetes Memory in Diabetes Study. This study comprised 2,977 individuals with mean age 62.5 years who had been recruited from August 2003 to December 2005 and then followed through June 2009. The purpose of the study was to examine the association of intensive versus standard glucose control on cognitive function. Participants underwent three neuropsychologic tests at baseline, 20 months, and 40 months. Tests included information processing speed, verbal memory, and executive function. Urine albumin measurements were carried out in parallel with the memory tests.

Results revealed that participants with albuminuria at baseline and follow-up (persistent albuminuria) and participants with albuminuria at follow-up but none at baseline (progressive albuminuria) had greater percentage declines on information processing speed than participants without albuminuria at baseline and at follow-up (no albuminuria). Persistent albuminuria and progressive albuminuria were associated with about a 5% decline in information processing speed scores but not with verbal memory or executive function performance.

Senior author Dr. Joshua Barzilay, an endocrinologist at Kaiser Permanente, said, “Our finding was a subtle change in cognition; however, were this decline to continue over 10 to 15 years it could translate into noticeable cognitive decline by the age of 75 to 80 years, when cognitive impairment generally becomes clinically evident. Given how common albuminuria and diabetes are in the older population, these findings have a great deal of importance from a population point of view. Moreover, albuminuria is also common among older people with hypertension without diabetes.”

The study was published in the August 29, 2013, online edition of the Clinical Journal of the American Society of Nephrology.

Related Links:

Kaiser Permanente of Georgia/Emory School of Medicine


Gold Member
Blood Gas Analyzer
GEM Premier 7000 with iQM3
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Auto-Chemistry Analyzer
CS-1200
New
Rocking Shaker
HumaRock

Print article

Channels

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.